Feasibility overview for an IV cannula, catheter and safety-needle plant in Saudi Arabia. Local production already exists (Alshifa Medical Products, Dammam), so the opportunity lies in specialised products, underserved segments or export. Plants require ISO 13485, an SFDA manufacturing establishment licence and medical device marketing authorisation (MDS-REQ 1).

Where Is the Opportunity?

With local production already present, the stronger opportunity is usually specialisation: advanced safety products, higher-spec catheters, uncovered segments or regional export.

Note

Do not assume there is no local production; a Dammam plant already operates.

Data Needed Before Deciding

  • Target products and sizes.
  • Target channels and tender volumes.
  • Assembly, moulding and sterilisation supplier quotations.
  • ISO 13485 QMS and validation plan.
  • Industrial site and utilities.

Study Stages

  1. Market and competition: Demand by product and channel; local and imported supply.
  2. Technical: Technology, capacity, automation, sterilisation, utilities.
  3. Regulatory: Establishment licence, marketing authorisation, validation.
  4. Financial and risk: Capex, opex, scenarios and sensitivity.

When Is It Suitable?

When there is an underserved product or segment, competitive cost, a realistic approval plan and enough working capital.

In a market with a local incumbent, specialisation beats volume.

FAQ

Is there a cannula factory in Saudi Arabia?

Yes, Alshifa Medical Products in Dammam lists IV cannulas, needles and syringes.

Which core certification is required?

ISO 13485 plus SFDA establishment licence and marketing authorisation.

Can I start with one product?

Yes; starting narrow then expanding is usually lower risk.

Does your project need an economic feasibility study?

Send Your Project Details and Start a Clear Feasibility Study

Request a Quote